Financials Shanghai Kinetic Medical Co., Ltd

Equities

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-19 pm EDT			5-day change	1st Jan Change
4.87 ^CNY	-2.01%		-2.01%	-23.06%

Apr. 23	Shanghai Kinetic Medical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 21	Shanghai Kinetic Medical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	9,681	11,324	7,586	5,163	4,539	3,492	-	-
Enterprise Value (EV) ¹	9,681	11,324	7,586	5,163	4,539	3,492	3,492	3,492
P/E ratio	32.3 x	-90.6 x	47.6 x	-243 x	40.3 x	28.6 x	24.4 x	20.3 x
Yield	0.37%	0.32%	0.47%	-	-	-	-	-
Capitalization / Revenue	7.92 x	10.7 x	5.98 x	-	4.75 x	3.08 x	2.57 x	2.15 x
EV / Revenue	7.92 x	10.7 x	5.98 x	-	4.75 x	3.08 x	2.57 x	2.15 x
EV / EBITDA	24.7 x	-219 x	19.4 x	-	-	17 x	14.5 x	12.4 x
EV / FCF	-	44,240,855 x	-	-	-	-	-	-
FCF Yield	-	0%	-	-	-	-	-	-
Price to Book	3.56 x	4.34 x	2.81 x	-	-	1.19 x	1.15 x	1.11 x
Nbr of stocks (in thousands)	714,463	714,463	711,633	717,026	717,013	717,013	-	-
Reference price ²	13.55	15.85	10.66	7.200	6.330	4.870	4.870	4.870
Announcement Date	2/25/20	4/25/21	4/27/22	4/21/23	4/21/24	-	-	-

¹CNY in Million²CNY

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	1,222	1,062	1,269	-	956.3	1,132	1,359	1,626
EBITDA ¹	391.6	-51.76	390.4	-	-	205.9	240.6	281.6
EBIT ¹	359.2	-87.19	218.8	-	-	166.4	195.8	229.2
Operating Margin	29.39%	-8.21%	17.25%	-	-	14.7%	14.41%	14.1%
Earnings before Tax (EBT) ¹	358.7	-87.27	216.3	-	-	159.9	189.3	222.7
Net income ¹	302.3	-126.5	161.8	-21.28	112.5	121.9	146.8	175.3
Net margin	24.73%	-11.92%	12.75%	-	11.77%	10.77%	10.8%	10.78%
EPS ²	0.4189	-0.1750	0.2241	-0.0296	0.1570	0.1700	0.2000	0.2400
Free Cash Flow	-	256	-	-	-	-	-	-
FCF margin	-	24.11%	-	-	-	-	-	-
FCF Conversion (EBITDA)	-	-	-	-	-	-	-	-
FCF Conversion (Net income)	-	-	-	-	-	-	-	-
Dividend per Share	0.0500	0.0500	0.0500	-	-	-	-	-
Announcement Date	2/25/20	4/25/21	4/27/22	4/21/23	4/21/24	-	-	-

¹CNY in Million²CNY

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt	-	-	-	-	-	-	-	-
Net Cash position	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Free Cash Flow	-	256	-	-	-	-	-	-
ROE (net income / shareholders' equity)	11.5%	-4.77%	6%	-	-	4.47%	5.1%	5.76%
ROA (Net income/ Total Assets)	8.38%	-3.4%	4.5%	-	-	-	-	-
Assets ¹	3,608	3,725	3,595	-	-	-	-	-
Book Value Per Share ²	3.800	3.660	3.800	-	-	4.100	4.240	4.400
Cash Flow per Share ²	0.3500	0.3900	0.5300	-	-	0.1900	0.1500	0.1700
Capex ¹	40.3	29	44.3	-	-	63.7	76.5	91.4
Capex / Sales	3.3%	2.73%	3.5%	-	-	5.62%	5.63%	5.62%
Announcement Date	2/25/20	4/25/21	4/27/22	4/21/23	4/21/24	-	-	-

¹CNY in Million²CNY

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

4.87 CNY

Average target price

4.76 CNY

Spread / Average Target

-2.26%

	1st Jan change	Capi.
SHANGHAI KINETIC MEDICAL CO., LTD	-23.06%	483M
ABBOTT LABORATORIES	-6.23%	180B
MEDTRONIC PLC	+2.59%	112B
BECTON, DICKINSON AND COMPANY	-2.75%	68.53B
DEXCOM, INC.	+5.32%	51.97B
CENCORA, INC.	+7.61%	44.08B
HOYA CORPORATION	+5.62%	42.23B
METTLER-TOLEDO INTERNATIONAL, INC.	+25.17%	32.43B
TERUMO CORPORATION	+16.72%	26.39B
WEST PHARMACEUTICAL SERVICES, INC.	-2.66%	24.97B